US’s Centers for Disease Control and Prevention (CDC) has on Thursday updated recommendations expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine over Johnson & Johnson’s COVID-19 vaccine. The recommendation was announced by CDC Director Dr. Rochelle Walensky late last night, hours after members of the agency’s Advisory Committee on Immunisation Practices voted in favor of the new recommendation. The panel convened following an update from the US FDA on the risk of rare but potentially life-threatening blood clots linked to the Johnson & Johnson vaccine.  “The U.S. supply of mRNA vaccines is abundant – with nearly 100 million doses in the field for immediate use. This updated CDC recommendation follows similar recommendations from other countries, including Canada and the UK. Given the current state of the pandemic both here and around the world, the ACIP reaffirmed that receiving any vaccine is better than being unvaccinated. Individuals who are unable or unwilling to receive an mRNA vaccine will continue to have access to Johnson & Johnson’s COVID-19 vaccine,” said a media release by CDC.